Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 52, 2017, Pages E11285-E11292

  Camporez, João Paulo ^a   Wang, Yongliang ^a   Faarkrog, Kasper ^a,b   Chukijrungroat, Natsasi ^a   Petersen, Kitt Falk ^a,b   Shulman, Gerald I ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ceramides; Diacylglycerol; Mitochondria; Protein kinase ; Protein kinase

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; DIACYLGLYCEROL; ISOENZYME; N-ACETYLTRANSFERASE 1; PRKCE PROTEIN, MOUSE; PROTEIN KINASE C EPSILON;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; ENERGY; ENZYME ACTIVITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER CELL; MOUSE; MPKCCD CELL LINE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SKELETAL MUSCLE; ANIMAL; DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; MITOCHONDRION; PATHOLOGY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; DIABETES MELLITUS, TYPE 2; DIGLYCERIDES; ENERGY METABOLISM; INSULIN RESISTANCE; ISOENZYMES; LIVER; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PROTEIN KINASE C-EPSILON; TRIGLYCERIDES;

EID: 85039703472     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1716990115     Document Type: Article

References (41)

1. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94:1543-1549.
2. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:87-91.
3. Ozcan L, Tabas I (2016) Calcium signalling and ER stress in insulin resistance and atherosclerosis. J Intern Med 280:457-464.
4. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: Common threads and missing links. Cell 148:852-871.
5. Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux. J Clin Invest 126:12-22.
6. Camporez JP, et al. (2013) Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology 154:1021-1028.
7. Jurczak MJ, et al. (2012) Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-boxbinding protein-1 (XBP1) knock-out mice. J Biol Chem 287:2558-2567.
8. Lee HY, et al. (2017) Mitochondrial-targeted catalase protects against high-fat dietinduced muscle insulin resistance by decreasing intramuscular lipid accumulation. Diabetes 66:2072-2081.
9. Shulman GI (2014) Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 371:1131-1141.
10. Holland WL, et al. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17:55-63.
11. Xia JY, et al. (2015) Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis. Cell Metab 22:266-278.
12. Xia JY, Morley TS, Scherer PE (2014) The adipokine/ceramide axis: Key aspects of insulin sensitization. Biochimie 96:130-139.
13. Knowles JW, et al.; RISC (Relationship between Insulin Sensitivity and Cardiovascular Disease) Consortium; EUGENE2 (European Network on Functional Genomics of Type 2 Diabetes) Study; GUARDIAN (Genetics UndeRlying DIAbetes in HispaNics) Consortium; SAPPHIRe (Stanford Asian and Pacific Program for Hypertension and Insulin Resistance) Study (2015) Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest 125:1739-1751.
14. Camporez JP, et al. (2013) Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Endocrinology 154:3099-3109.
15. Camporez JP, et al. (2015) Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21. J Endocrinol 226:207-217.
16. Camporez JP, et al. (2015) ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content. J Lipid Res 56:526-536.
17. Samuel VT, et al. (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345-32353.
18. Samuel VT, et al. (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 117:739-745.
19. Petersen MC, et al. (2016) Insulin receptor Thr1160 phosphorylation mediates lipidinduced hepatic insulin resistance. J Clin Invest 126:4361-4371.
20. Petersen KF, et al. (2003) Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300:1140-1142.
21. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671.
22. Petersen KF, et al. (2015) Effect of aging on muscle mitochondrial substrate utilization in humans. Proc Natl Acad Sci USA 112:11330-11334.
23. Befroy DE, et al. (2007) Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 56:1376-1381.
24. Perry RJ, et al. (2015) Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160:745-758.
25. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176.
26. Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: Unravelling the mechanism. Lancet 375:2267-2277.
27. Lee HY, et al. (2010) Targeted expression of catalase to mitochondria prevents ageassociated reductions in mitochondrial function and insulin resistance. Cell Metab 12: 668-674.
28. Choi CS, et al. (2007) Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest 117:1995-2003.
29. Kim JK, et al. (2004) PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114:823-827.
30. Yu C, et al. (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236.
31. Kumashiro N, et al. (2011) Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 108:16381-16385.
32. Ter Horst KW, et al. (2017) Hepatic diacylglycerol-associated protein kinase Ce translocation links hepatic steatosis to hepatic insulin resistance in humans. Cell Rep 19:1997-2004.
33. Szendroedi J, et al. (2014) Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci USA 111:9597-9602.
34. Perry RJ, et al. (2013) Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. Cell Metab 18:740-748.
35. Perry RJ, Zhang D, Zhang XM, Boyer JL, Shulman GI (2015) Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347: 1253-1256.
36. Chennamsetty I, et al. (2016) Nat1 deficiency is associated with mitochondrial dysfunction and exercise intolerance in mice. Cell Rep 17:527-540.
37. Tschöp MH, et al. (2011) A guide to analysis of mouse energy metabolism. Nat Methods 9:57-63.
38. Bonnard C, et al. (2008) Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118:789-800.
39. Zhang D, et al. (2007) Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci USA 104:17075-17080.
40. Morino K, et al. (2005) Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115:3587-3593.
41. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.